Future studies to examine the ability of the SLP vaccine-induced T cells and OX40 costimulation to boost immune responses in immunocompromised settings of CMV infection or other chronic viral infections are strongly encouraged by these promising findings. This evidence concerns the gene TNFRSF4 and cytomegalovirus infection.